The Latest Biology News And Medical NewsBiology News 2Health News 2Biology News 3Health News 3
HOME >> MEDICINE >> NEWS
Health care treatment differs by race

A UC Riverside study found that African-Americans and Latinos seeking treatment for back pain were prescribed pain relievers less often than were white patients.

The research, by Augustine J. Kposowa, a sociology professor, is in the latest edition of "Race & Society," the journal of the Association of Black Sociologists, published by Elsevior.

In "Searching for Relief: Racial Differences in Treatment of Patients with Back Pain," Kposowa and co-author Glenn T. Tsunokai of Western Washington University in Bellingham broke down data from the U.S. National Hospital Ambulatory Medical Care Survey, 1995 through 1998. They found African-American and Hispanic outpatients complaining of back pain were "considerably less likely" than whites to receive painkillers at hospitals and in emergency rooms throughout the United States.

The study contends that prejudice and racial stereotyping among physicians is the most plausible explanation for racial differences in pain treatment. It notes that there was no significant difference among the races in the numbers of referrals for X-rays, MRI tests and CT scans.

Early studies have explained the variations in pain treatment across racial and ethnic lines as a function of differing levels of medical coverage, the authors say in the introduction to the 30-page paper. Later studies, including this one, have taken that and other financial factors into account and still find deep differences.

The study focused on three variables: whether patients were advised to take any pain-relief medication; whether prescription drugs were ordered; and how many medications were prescribed. Results were given for Hispanics, African-Americans, whites and Asians across several age groups.

African-American men were least likely to get prescriptions, the study indicates, followed by Hispanic men. African-American men also were least likely to be advised to take over-the-counter pain relievers.

Wh
'"/>

Contact: Kris Lovekin
kris.lovekin@ucr.edu
909-787-2495
University of California - Riverside
24-May-2004


Page: 1 2 3

Related medicine news :

1. Mailman School of Public Health receives Manhattan Tobacco Cessation Center grant
2. Liverpool to lead 20M Department of Health initiative to develop medicines for children
3. Health care report cards may increase racial/ethnic disparities in bypass operations
4. 2005 Behavioral Sciences & Health Services Research Award
5. Statement on the findings of the Womens Health Study
6. Bone density returns when teens stop using Depo Provera, Group Health study finds
7. Mailman School of Public Health researchers develop infectious disease diagnostic tool
8. Health initiatives can help peace building in the Middle East
9. Study naming hospitals in top 5% for clinical quality released by HealthGrades
10. RelayHealth selected by Columbia University to link doctors and patients online
11. Health report-card fears make doctors forgo potential life-saving heart treatment

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Health care treatment differs race

(Date:11/23/2009)...age are more than twice as likely to develop demen...the Sahlgrenska Academy. , The study has just be.... , "Anyone carrying a lot of fat around the mid... a heart attack or stroke," says Deborah Gustafson...they nevertheless manage to live beyond 70, they r...
(Date:11/23/2009)... of Agriculture (USDA) has awarded a two-year, $90... Minnesota to complete sequencing the genome of th...nding will be used by the Turkey Genome Sequencing...g next-generation sequencing platforms, assemble t...ns in the final genome sequence by use of a sophis...
(Date:11/23/2009)...lationHealthPrograms ,, LOVELAND,Ohio,Nov.23/P...stitute(PHII),anon-profit501(c)(3)organization,isp...ovedtheHealthcareTransparencyAccreditationProgram,...M),alife,health,andwellnesscompanybasedinFarmingto...tationsealforfiveofitsprograms. ,, ThomasW.Wils...
(Date:11/23/2009)...il to the diet could reduce the risk of osteoporos...s, according to a report to be published in the I... Public Health . , Mer Harvi and colleagues at t... studied the effect of diabetes on bone health and...y the onset of osteoporosis. The researchers studi...
(Date:11/23/2009)...re blacks die than whites, study finds , ... and co-existing health problems don,t explain why...ates than whites, U.S. researchers say. , In an...l rates than whites for nearly all cancers, includ...ariety factors, such as differences in health care...
Breaking Medicine News(10 mins):Health News:Turkey Genome Sequencing Consortium awarded $0.9 million from USDA 2Health News:Population Health Impact Institute Launches Healthcare Transparency Accreditation Program(TM) 2Health News:Population Health Impact Institute Launches Healthcare Transparency Accreditation Program(TM) 3Health News:Flaxseed oil and osteoporosis 2Health News:Weight May Not Drive Racial Disparities in Colon Cancer 2
(Date:11/23/2009)...ATO,Calif.,Nov.23/PRNewswire-FirstCall/--RaptorPha...PTP ),todayannouncedresultsfromaPhase2bclinicaltri...ate("DRCysteamine")inpatientswithnephropathiccysti...ityofCalifornia,SanDiego("UCSD")GeneralClinicalRes...ineticsandpharmacodynamicsofasingledoseofDRCysteam...
(Date:11/23/2009)...VERN,Pa.andFRAZER,Pa.,Nov.23/PRNewswire-FirstCall/...ceuticalcompany,andCephalon,Inc.(Nasdaq: CEPH )tod...rCINQUIL(TM)(reslizumab)asatreatmentforpediatriceo...aluateimprovementintheco-primaryendpointsofchanges...alysesofthedataindicatedthatpatientstreatedwithCIN...
(Date:11/23/2009)...INE,Calif.,Nov.23/PRNewswire/--AdvancedSterilizati...olutionprovider,announcedtodaytheacquisitionbyitsF...elyhelddeveloperofinnovativedisinfectionprocessesa...ns.Termsoftheacquisitionwerenotdisclosed. ,, Gl...aminationtechnologythatprovidesdisinfectionofpatie...
Breaking Medicine Technology:Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis 2Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis 3Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis 4Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis 5Ception Therapeutics and Cephalon Provide Initial Results of a Phase IIb/III Study of CINQUIL in Pediatric Eosinophilic Esophagitis 2Ception Therapeutics and Cephalon Provide Initial Results of a Phase IIb/III Study of CINQUIL in Pediatric Eosinophilic Esophagitis 3Ception Therapeutics and Cephalon Provide Initial Results of a Phase IIb/III Study of CINQUIL in Pediatric Eosinophilic Esophagitis 4ASP Announces Acquisition of Gloster Europe to Help Reduce Infections in Healthcare Facilities 2AMDL Inc Announces Second Quarter 2009 Financial Results 54924 1AMDL Inc Announces Second Quarter 2009 Financial Results 54924 2AMDL Inc Announces Second Quarter 2009 Financial Results 54924 3AMDL Inc Announces Second Quarter 2009 Financial Results 54924 4AMDL Inc Announces Second Quarter 2009 Financial Results 54924 5AMDL Inc Announces Second Quarter 2009 Financial Results 54924 6AMDL Inc Announces Second Quarter 2009 Financial Results 54924 7Stenting a Good Option for Left Main Heart Artery 54922 1Stenting a Good Option for Left Main Heart Artery 54922 2Stenting a Good Option for Left Main Heart Artery 54922 3Chindex International Inc Announces New CDC Contract 54917 1Chindex International Inc Announces New CDC Contract 54917 2Chindex International Inc Announces New CDC Contract 54917 3
Other News:
African American and white women who are treated with tamoxifen for breast cancer appear to have the same risks of contralateral breast cancer and thromboembolic events, according to a new study in th
...a were established many years ago. However, lack ...new influenza subtypes to spread in pandemics repr...alleviate supply issues, some public health expert...l this be adequate to protect high-risk population...
... will actively debate the use of oral pills for er... European Society for Sexual Medicine in London, U...MD, editor of the Journal of Sexual Medicine, the ... 2004 in the Palace Suite of the Hilton London Met...
... learning problems after their central nervous sys...n appear to benefit from treatment with methylphen...name Ritalin. This finding, from investigators at ...ed in the Dec. 1 issue of the Journal of Clinical ...
health news:Tamoxifen's risks similar in African American and white women 2health news:Academy meeting examines the vaccine & avian influenza crisis 2health news:Methylphenidate improves attention, behavior of children surviving leukemia, brain tumors 2
... on a promising diabetes treatment. In the Octobe... Masaru Taniguchi and colleagues report that trans...n the activation of a specific type of immune cell...used by the destruction of the insulin-producing c...
...00 people in the United States per year. A blockag...rcent of strokes. Carotid endarterectomy is the mo...e. There is scientific evidence to support its use... practice guideline published in the September 27,...
...ients at the time of HIV diagnosis is cost-effecti...ording to an article in the Nov. 1 issue of Clinic.....Resistance to antiretroviral therapy, even in pa...wing concern. However, genotype resistance testing...
... practice driving on a computer-generated course c...archers have found.......Patients who received sim...s stroke patients without the training to pass an ...aining period, according to Dr. Abiodun Akinwuntan...
health news:Updated guideline: Carotid endarterectomy beneficial for stroke prevention in some patients 2health news:Drug resistance testing in treatment-nave HIV patients is cost-effective 2health news:Simulator can help stroke patients drive again 2